PEAK6’s NeoGenomics NEO Stock Holding History

PEAK6’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,200	Closed	-$213K	–	3297
2025 Q2	$213K	Sell	29,200 -6,300	-18%	-$50.8K	﹤0.01%	2435
2025 Q1	$337K	Buy	+35,500	New	+$443K	﹤0.01%	2235

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

PEAK6's NEO Position: Q2 2026 in Review

PEAK6 opened a new position in NeoGenomics (NEO) in Q2 2026: 25,575 shares worth $373K. The stake represents ﹤0.01% of the portfolio and ranks #2080 among its holdings. This is a return to the name: PEAK6 previously reported a position in NEO as recently as Q2 2025.

PEAK6 first reported a position in NEO in Q1 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

PEAK6 held 25,575 shares of NeoGenomics worth $373K as of Q2 2026.
NeoGenomics was a new PEAK6 position in Q2 2026.
NeoGenomics made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2080 holding.
PEAK6 first reported a position in NeoGenomics in Q1 2025 and has held it in 3 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.